The II National Interdisciplinary Congress “Comorbid Neurology” took place in Moscow on October 11-12, sponsored by the NAEKN. Experts from Russia and neighboring countries lectured, and practical master classes on neurological diagnostics and treatment were conducted.
The Sotex company held a symposium addressing the rising cognitive impairment due to unhealthy lifestyles, obesity, diabetes, and hypertension.Reports highlighted the role of Sotex and Rafarma drugs in treating cognitive impairment, presenting new clinical trial data on Cereton and Neipilept. Speakers emphasized the convenience and cost-effectiveness of new dosage forms.
“Cereton” solution for oral administration and “Neypilept” solution for oral administration in a large bottle volume, sufficient for 1 month of therapy. The solution form is convenient for swallowing by an elderly patient.
“Cereton” capsules in large packaging designed for 1 month of therapy and “Neypilept” tablets – for ease of administration by young and middle-aged patients.
In addition, reports were presented on chondroprotectors of the company “Sotex” – “Hondrograd” and “Sustagard“, presented not only by leaders from different cities of Russia, but also from the CIS countries.
